{
  "name": "Generate Biomedicines, Inc.",
  "legal_name": "Generate Biomedicines, Inc.",
  "ticker": "GENB",
  "tickers": [
    "GENB"
  ],
  "cik": "0002100782",
  "page_url": "https://steadybase.io/company/generate-biomedicines-inc/",
  "markdown_url": "https://steadybase.io/company/generate-biomedicines-inc.md",
  "json_url": "https://steadybase.io/company/generate-biomedicines-inc.json",
  "as_of": "2026-11-10",
  "last_filed": "2026-08-06",
  "industry": {
    "sic": "2834",
    "description": "Pharmaceutical Preparations"
  },
  "headquarters": {
    "city": "Somerville",
    "state": "MA",
    "country": "US"
  },
  "exchanges": [
    "Nasdaq"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "<br>Emerging growth company",
  "state_of_incorporation": "DE",
  "website": "generatebiomedicines.com",
  "investor_relations_url": "https://investors.generatebiomedicines.com/",
  "linkedin_company_url": "https://www.linkedin.com/company/generate-biomedicines",
  "summary": {
    "text": "We are a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. Our vision is to program biology to generate optimal therapeutics for the greatest impact on human health. Central to our vision is the Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies.",
    "section": "Item 1. Business",
    "period_end": "2026-02-27",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526083190/generate_bio_424b4.htm"
  },
  "key_facts": [
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 128352436,
      "unit": "shares",
      "period_end": "2026-07-29",
      "form": "10-Q",
      "filed": "2026-08-06",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526336437/0001193125-26-336437-index.html",
      "text": "Shares outstanding: 128,352,436 as of Jul 29, 2026 (10-Q filed Aug 6, 2026)."
    }
  ],
  "metrics": {},
  "next_earnings": {
    "date": "2026-11-14",
    "confidence": "estimate",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Michael Nally",
      "title": "Chief Executive Officer",
      "role": "both",
      "linkedin_url": "https://www.linkedin.com/in/michael-nally-0a137299",
      "form": "4",
      "filed": "2026-03-06",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526096799/0001193125-26-096799-index.htm"
    },
    {
      "name": "Jason Silvers",
      "title": "President & CFO",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/jason-silvers-b2975323b",
      "form": "4",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085898/0001193125-26-085898-index.htm"
    },
    {
      "name": "Beth Grous",
      "title": "Chief People Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085939/0001193125-26-085939-index.htm"
    },
    {
      "name": "Gevorg Grigoryan",
      "title": "Chief Technology Officer",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/gevorg-grigoryan-953a8113",
      "form": "4",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085886/0001193125-26-085886-index.htm"
    },
    {
      "name": "Laurie Anne Lee",
      "title": "Chief Medical Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085911/0001193125-26-085911-index.htm"
    },
    {
      "name": "Sean Martin",
      "title": "Chief Legal Officer & GC",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/sean-martin-2926664",
      "form": "4",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085910/0001193125-26-085910-index.htm"
    },
    {
      "name": "Aarif Khakoo",
      "title": "Chief Scientific Officer",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/aarif-khakoo-a134b64",
      "form": "3",
      "filed": "2026-02-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526078381/0001193125-26-078381-index.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-08-26",
      "items": [
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526365556/ck0002100782-20260825.htm"
    },
    {
      "filed": "2026-08-06",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526336462/ck0002100782-20260806.htm"
    },
    {
      "filed": "2026-05-07",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526209899/ck0002100782-20260507.htm"
    },
    {
      "filed": "2026-03-02",
      "items": [
        {
          "item": "5.03",
          "label": "Amendments to articles or bylaws; change in fiscal year",
          "signal": "governance"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085780/ck0002100782-20260226.htm"
    }
  ],
  "insider_trades": [
    {
      "owner": "Frances Arnold",
      "role": "Director",
      "action": "sold",
      "code": "S",
      "shares": 11409,
      "value_usd": 184733,
      "date": "2026-10-29",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526447199/0001193125-26-447199-index.htm"
    },
    {
      "owner": "Frances Arnold",
      "role": "Director",
      "action": "sold",
      "code": "S",
      "shares": 1000,
      "value_usd": 16000,
      "date": "2026-09-01",
      "filed": "2026-09-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526381875/0001193125-26-381875-index.htm"
    },
    {
      "owner": "Michael Nally",
      "role": "Chief Executive Officer",
      "action": "bought",
      "code": "P",
      "shares": 20000,
      "value_usd": 240000,
      "date": "2026-03-04",
      "filed": "2026-03-06",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526096799/0001193125-26-096799-index.htm"
    },
    {
      "owner": "Beth Grous",
      "role": "Chief People Officer",
      "action": "bought",
      "code": "P",
      "shares": 300,
      "value_usd": 4800,
      "date": "2026-03-02",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085939/0001193125-26-085939-index.htm"
    },
    {
      "owner": "Jason Silvers",
      "role": "President & CFO",
      "action": "bought",
      "code": "P",
      "shares": 2000,
      "value_usd": 32000,
      "date": "2026-03-02",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085898/0001193125-26-085898-index.htm"
    },
    {
      "owner": "Noubar Afeyan",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 4687500,
      "value_usd": 75000000,
      "date": "2026-03-02",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085888/0001193125-26-085888-index.htm"
    },
    {
      "owner": "Jane L. Mendillo",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 1500,
      "value_usd": 24000,
      "date": "2026-03-02",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085872/0001193125-26-085872-index.htm"
    },
    {
      "owner": "Noubar Afeyan",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 4687500,
      "value_usd": 75000000,
      "date": "2026-03-02",
      "filed": "2026-03-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526085855/0001193125-26-085855-index.htm"
    }
  ],
  "quotes": [
    {
      "text": "Our team’s focus on execution for our clinical programs and translating our generative biology platform into the next generation of differentiated medicines drove strong progress in the second quarter",
      "speaker": "Mike Nally",
      "title": "chief executive officer of Generate Biomedicines Inc",
      "form": "8-K",
      "filed": "2026-08-06",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526336462/ck0002100782-ex99_1.htm"
    },
    {
      "text": "Our platform and continued pipeline progress create optionality",
      "speaker": "Jason Silvers",
      "title": "president and chief financial officer of Generate Biomedicines Inc",
      "form": "8-K",
      "filed": "2026-08-06",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526336462/ck0002100782-ex99_1.htm"
    }
  ],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-08-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526365556/ck0002100782-20260825.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-08-06",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526336437/ck0002100782-20260630.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}